肺超声筛查无症状类风湿关节炎相关间质性肺病的多中心研究
本研究为多中心横断面研究,纳入203例无症状类风湿关节炎患者,评估肺超声(LUS)诊断间质性肺病(ILD)的性能。结果显示26%患者确诊ILD,LUS灵敏度83%、特异度81.2%、阴性预测值93.1%,优于肺功能检查,提示LUS可作为一线筛查工具。
要点
- 无症状类风湿关节炎患者中26%存在ILD。
- LUS灵敏度83%、特异度81.2%、阴性预测值93.1%。
- LUS筛查性能优于肺功能检查。
核心结论
- LUS是筛查无症状类风湿关节炎患者ILD的有前景工具,具有高灵敏度和阴性预测值。
研究设计与样本
- 多中心横断面研究,纳入阿根廷、希腊、法国和墨西哥门诊的203例无症状类风湿关节炎患者,均接受临床评估、肺功能检查和LUS,并在LUS后30天内完成HRCT。
主要发现
- 26%的患者诊断为ILD,中位年龄63岁(52-89岁),女性161例(79.3%),从类风湿关节炎诊断到入组的中位时间为7年(范围2-16年)。
- LUS灵敏度83%(95% CI 70.2%-91.9%),特异度81.2%(95% CI 74.2%-87.2%),阴性预测值93.1%(95% CI 87.4%-96.8%),阳性预测值61.1%(95% CI 58.9%-72.4%)。
- LUS性能优于肺功能检查。
临床怎么用
- 可考虑将LUS纳入无症状类风湿关节炎患者的常规临床实践,以优化ILD筛查策略并通过早期发现和干预改善患者结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The screening strategy for interstitial lung disease (ILD) in patients with rheumatoid arthritis is currently debated. Although high-resolution CT (HRCT) imaging is the gold standard for diagnosing ILD, its systematic use as a screening tool is not yet recommended. The role of lung ultrasound (LUS) in assessing ILD has been previously explored. RESEARCH QUESTION: What is the performance of LUS for ILD diagnosis in asymptomatic patients with rheumatoid arthritis? STUDY DESIGN AND METHODS: We conducted a multicenter, cross-sectional study involving 203 asymptomatic patients with rheumatoid arthritis from outpatient clinics in Argentina, Greece, France, and Mexico. Participants underwent clinical evaluations, pulmonary function tests, and LUS. An HRCT scan was performed on each patient within 30 days of the LUS. Statistical analyses included sensitivity, specificity, and predictive values for LUS and pulmonary function tests. RESULTS: Of the participants, 26% were diagnosed with ILD. The median age was 63 years (52-89 years), and 161 (79.3%) patients were female. The median duration from rheumatoid arthritis diagnosis to inclusion was 7 years (range, 2-16 years). LUS exhibited a sensitivity of 83% (95% CI, 70.2%-91.9%) and a specificity of 81.2% (95% CI, 74.2%-87.2%), with a negative predictive value of 93.1% (95% CI, 87.4%-96.8%) and a positive predictive value of 61.1% (95% CI, 58.9%-72.4%). LUS outperformed pulmonary function tests, underscoring its potential as a primary screening tool. INTERPRETATION: Our results suggest that LUS is a promising tool for ILD screening in asymptomatic patients with rheumatoid arthritis, offering high sensitivity and negative predictive value. Its incorporation into routine clinical practice could optimize ILD screening strategies and enhance patient outcomes through early detection and intervention.
引用
- Otaola M, Vasarmidi E, Ottaviani S, et al. Performance of Lung Ultrasound as a Screening Tool for Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multicenter Study. Chest. 2024. PMID: 39675519. doi:10.1016/j.chest.2024.11.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。